-transparent.png){kind=logo}
Aldosterone responsiveness to consecutive i.v. injections of metoclopramide 1 mg, 2.5 mg and 10 mg was studied in 8 patients with prolactinoma and normally preserved adrenal function and in 14 healthy volunteers. In the patients, aldosterone response to metoclopramide 1 mg was blunted. After metoclopramide 10 mg, aldosterone rose to the same levels in patients and volunteers. In the patients, however, percentage rise of aldosterone was enhanced, since the appropriate base line concentration of aldosterone was decreased. Thus, there is evidence for increased endogenous dopaminergic inhibition of aldosterone secretion in prolactinoma.
Related Publications
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
June 1987,
Fortschritte der Medizin,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
February 1985,
Neurosurgery,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
January 1983,
The Tohoku journal of experimental medicine,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
December 1986,
Fortschritte der Medizin,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
November 1981,
The Journal of endocrinology,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
April 1992,
Endocrinologia japonica,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
July 1980,
American journal of obstetrics and gynecology,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
December 1983,
Clinical endocrinology,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
December 1981,
Circulation research,
E Jungmann, and
U Schwedes, and
P H Althoff, and
C Rosak, and
K Schöffling
February 1982,
The Journal of clinical endocrinology and metabolism,
